From the Guidelines
Diagnosis and treatment of Aspergillosis with osteomyelitis at the base of the skull is a complex process that requires aggressive diagnostic and therapeutic intervention.
Diagnosis
The diagnosis of Aspergillosis with osteomyelitis at the base of the skull involves a combination of clinical, radiological, and microbiological findings.
- Key diagnostic tools include:
Treatment
The primary treatment for Aspergillosis with osteomyelitis at the base of the skull is voriconazole, which is recommended as the primary systemic antifungal therapy (A-II) 1.
- Alternative treatments include:
- Surgical intervention is also recommended, where feasible, to prevent serious neurological sequelae and improve outcome 1
- Reversal of underlying immune deficits is paramount for successful outcome of CNS aspergillosis 1
- Corticosteroids should be avoided where possible, as they can be deleterious in this context (C-III) 1
Additional Considerations
- Duration of therapy has not been optimally defined, but most experts attempt to treat pulmonary infection until resolution or stabilization of all clinical and radiographic manifestations 1
- Prophylaxis against invasive aspergillosis may be necessary for patients who require subsequent immunosuppression after successful treatment of IA 1
From the Research
Diagnosis of Aspergillosis with Osteomyelitis at the Base of the Skull
- The diagnosis of Aspergillosis with osteomyelitis at the base of the skull can be challenging due to its rarity and non-specific symptoms 2, 3.
- A combination of clinical examination, laboratory findings, imaging studies (CT and MRI), and serum galactomannan assay can aid in diagnosis 2, 4.
- Fungal culture and histopathology are essential for definitive diagnosis 4.
- The presence of lower cranial nerve palsies and lack of response to culture-directed antibiotics may indicate a fungal etiology 2.
Treatment of Aspergillosis with Osteomyelitis at the Base of the Skull
- The treatment of Aspergillosis with osteomyelitis at the base of the skull typically involves antifungal therapy, with or without surgical intervention 5, 4.
- Voriconazole is a commonly used antifungal agent for the treatment of Aspergillus osteomyelitis 4.
- Surgical debridement may be necessary in some cases to remove infected tissue and promote healing 5, 4.
- The duration of antifungal therapy can vary, but prolonged treatment (median 90 days) is often necessary to achieve a complete response 5.
- Early diagnosis and treatment are crucial to improve outcomes and reduce mortality 3, 6.
Clinical Presentation and Epidemiology
- Aspergillosis with osteomyelitis at the base of the skull can affect both immunocompromised and immunocompetent patients 5.
- The most common sites of infection are the vertebrae, cranium, and ribs 5.
- Patients with underlying medical conditions, such as diabetes mellitus, chronic otitis externa, and immunosuppression, are at increased risk of developing fungal osteomyelitis 2, 3.
- The clinical presentation can vary, but common symptoms include pain, tenderness, and cranial nerve deficits 2, 5.